Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes

This study has been terminated.

( This trial was terminated due to low recruitment )

Study NCT00267683 Information provided by Novo Nordisk

First Received: December 20, 2005 Last Updated: September 23, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	April 2006
Primary Completion Date:	April 2006 (Final data collection date for primary outcome measure)